Please enable Javascript on your browser for a better experience.
The Triglycerides Test measures triglyceride levels in blood to evaluate heart health and metabolic function. High levels may increase risk for cardiovascular disease, atherosclerosis, or pancreatitis, while low levels may reflect nutritional issues. Doctors use this test as part of lipid screening to assess patients with obesity, diabetes, or high cholesterol. Results provide vital insight into fat metabolism, cardiovascular risk, and overall wellness management.
The Cardio IQ™ Triglycerides Test measures triglyceride levels in the blood, an important marker of lipid metabolism and cardiovascular health. Elevated triglycerides are linked to increased risk of heart disease, pancreatitis, and metabolic syndrome. Physicians use this test to assess risk factors, monitor therapy response, and guide lifestyle or treatment decisions, often as part of a broader lipid or heart health evaluation.
The Triglyceride Driver Identification Panel combines triglycerides with apolipoprotein C-III testing to reveal not just elevated fat levels, but the underlying regulatory drivers. By identifying impaired triglyceride breakdown and clearance, this advanced blood panel provides deeper insight into cardiometabolic risk beyond standard lipid testing and supports more precise evaluation of persistent or unexplained triglyceride elevation.
ApoC-III Triglyceride Driver Panel
The Lipid Panel Test with Reflex to Direct LDL measures total cholesterol, HDL, LDL, triglycerides, and cholesterol ratios to assess heart and vascular health. If triglycerides are very high, it automatically reflexes to direct LDL measurement for greater accuracy. Doctors use this test to evaluate cardiovascular risk, guide cholesterol management, and monitor therapy. Results provide key insight into lipid balance, heart disease prevention, and metabolic health.
The Lipid Panel Test checks six key blood lipids: total cholesterol, HDL cholesterol, LDL cholesterol, non-HDL cholesterol, triglycerides, and the Chol/HDL ratio. This panel assesses risk for cardiovascular disease, heart attack, and stroke by evaluating cholesterol balance and fat levels in the blood. Doctors use lipid panel results for routine screening, treatment monitoring, and guiding lifestyle or medication adjustments.
The AALP Apolipoprotein C3 Test measures apolipoprotein C-III, a key regulator of triglyceride metabolism and lipoprotein clearance. Elevated ApoC-III levels are linked to impaired triglyceride breakdown, atherogenic remnant particles, and increased cardiometabolic risk. This advanced blood test provides deeper insight beyond standard lipid panels, helping identify hidden cardiovascular and metabolic risk and supporting more personalized lipid health assessment.
The Direct LDL Test measures low-density lipoprotein (LDL) cholesterol directly, without requiring fasting or calculation from triglycerides. LDL is known as “bad cholesterol” because high levels contribute to plaque buildup, heart disease, and stroke risk. Doctors order this test for patients with diabetes, high triglycerides, or cardiovascular risk. Results provide accurate insight into lipid health, helping guide treatment, prevention, and heart disease management.
The Lipoprotein Electrophoresis Test evaluates lipid metabolism by measuring the distribution of major lipoprotein classes such as HDL, LDL, VLDL, and chylomicrons. This test can reveal dyslipoproteinemias, detect abnormal lipid transport, and support assessment of cardiovascular and metabolic health. It offers a more detailed profile than routine cholesterol testing, highlighting underlying patterns that contribute to atherosclerosis risk.
The VLDL Cholesterol Test measures very low-density lipoprotein cholesterol, which carries triglycerides in the blood. High VLDL levels are linked to heart disease, atherosclerosis, and metabolic syndrome. Doctors order this test as part of a lipid panel to assess cardiovascular risk, monitor treatment, or evaluate high triglycerides. Results provide critical insight into lipid metabolism, helping guide lifestyle changes, therapy, and long-term heart health management.
The Cardio IQ™ Direct LDL Test directly measures low-density lipoprotein cholesterol (LDL-C), the “bad cholesterol” linked to atherosclerosis and cardiovascular disease. Unlike calculated LDL, this test provides accurate results even with high triglycerides or non-fasting samples. Doctors use it to assess heart disease risk, guide therapy decisions, and monitor patients on lipid-lowering treatments to improve cardiovascular health outcomes.
The Lipid Panel with Ratios Test measures seven key markers: total cholesterol, HDL, LDL, non-HDL cholesterol, triglycerides, Chol/HDL ratio, and LDL/HDL ratio. This advanced panel evaluates cardiovascular risk by assessing cholesterol balance and fat metabolism. Doctors use it to detect high cholesterol, atherosclerosis risk, and heart disease, and to monitor treatment. Often part of routine exams, it provides insight into long-term heart and metabolic health.
The Cardio IQ™ Apolipoprotein B Test measures ApoB, the main protein in LDL and other atherogenic lipoproteins. Elevated ApoB levels are linked to higher cardiovascular risk. This test provides a more precise assessment of heart disease risk than standard cholesterol tests and helps guide treatment decisions.
The Apolipoprotein A1 and B Test measures Apo A1, the main protein in HDL cholesterol, and Apo B, the primary protein in LDL and VLDL cholesterol. Together, these markers and the ApoB/A1 ratio provide a clearer picture of cardiovascular risk than standard lipid panels. High ApoB or low Apo A1 may signal heart disease, stroke, or atherosclerosis. Doctors use this test to evaluate cholesterol balance, monitor therapy, and guide prevention of cardiovascular conditions.
The Cardio IQ™ ApoE Genotype Test analyzes apolipoprotein E (ApoE) gene variants linked to cholesterol metabolism and cardiovascular risk. Results help assess risk for heart disease, hyperlipidemia, and Alzheimer’s disease. This genetic test guides personalized prevention and treatment strategies, including diet, lifestyle, and lipid-lowering therapies, supporting long-term cardiovascular and brain health.
The Cardio IQ™ Apolipoprotein Evaluation Test measures both ApoA1, the main protein in HDL, and ApoB, the main protein in LDL and other atherogenic lipoproteins. The balance between these markers provides a detailed assessment of cardiovascular risk, lipid metabolism, and helps guide heart disease prevention and treatment.
The Remnant & Particle Burden Panel evaluates advanced lipid, particle, and inflammatory markers to uncover hidden cardiovascular risk. By combining a comprehensive lipid panel with ApoB, ApoC-III, Direct LDL, hs-CRP, and Lipoprotein (a), this blood test assesses atherogenic particle number, remnant burden, inherited risk, and vascular inflammation beyond standard cholesterol testing.
Advanced Remnant & Particle Risk Panel
The Apolipoprotein B (ApoB) Test measures ApoB, the main protein in LDL and VLDL cholesterol, to assess cardiovascular risk. Elevated ApoB is linked to atherosclerosis, coronary artery disease, heart attack, and stroke. Low levels may reflect liver disease or malnutrition. Doctors often order this test with lipid panels or Apo A1 to calculate the ApoB/A1 ratio, providing a more accurate picture of cholesterol balance, cardiovascular health, and risk for heart disease.
The Homocysteine Test measures homocysteine levels in blood to assess risk for heart disease, stroke, and vascular problems. Elevated homocysteine may result from vitamin B6, B12, or folate deficiency and is linked to blood clots, cognitive decline, and osteoporosis. Doctors use this test to evaluate cardiovascular risk, monitor nutritional deficiencies, and guide treatment for metabolic or genetic conditions affecting homocysteine metabolism.
Why pay $49 for Everlywell's Cholesterol & Lipids finger prick test kit when you can experience the convenience and affordablity of a Cholesterol & Lipids lab test with Ulta Lab Tests - compare now and save!
The Advanced TRL Phenotyping & Therapy Readiness Panel provides a detailed evaluation of triglyceride-rich lipoproteins, atherogenic particle burden, inflammation, and metabolic readiness. By combining advanced lipid, NMR particle analysis, ApoB, ApoC-III, insulin, liver function, and OmegaCheck testing, this blood panel delivers deep insight into remnant-driven cardiovascular risk beyond standard cholesterol testing.
Severe Hypertriglyceridemia Precision Panel
The Apolipoprotein A1 (Apo A1) Test measures levels of Apo A1, the main protein in HDL cholesterol, to assess heart and vascular health. Higher levels are linked to protective “good” cholesterol, while low levels may increase risk of heart disease, stroke, or metabolic disorders. Doctors use this test with lipid panels to evaluate cardiovascular risk, monitor therapy, and guide prevention strategies for cholesterol balance and heart health.
The Cholesterol and Lipids Base Test evaluates key blood fats, including total cholesterol, HDL, LDL, non-HDL cholesterol, and triglycerides. It also calculates important ratios to give a clearer picture of heart health, helping identify risks and guide management of cardiovascular disease.
The Cholesterol and Lipids Test measures Cholesterol, Total; HDL; LDL; Non-HDL; Triglycerides; and the Chol/HDLC Ratio to assess heart health and cardiovascular risk. High LDL or triglycerides and low HDL may indicate increased risk of heart disease or stroke. Doctors use this test to monitor cholesterol levels, evaluate therapy, and guide lifestyle or treatment decisions. It provides vital insight into lipid balance and long-term cardiovascular wellness.
